Charles Schwab’s Achillion Pharmaceuticals ACHN Stock Holding History

Charles Schwab’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-838,078	Closed	-$5.05M	–	3269
2019 Q4	$5.05M	Buy	838,078 +3,881	+0.5%	+$22.5K	﹤0.01%	2007
2019 Q3	$3M	Buy	834,197 +38,958	+5%	+$150K	﹤0.01%	2231
2019 Q2	$2.13M	Buy	795,239 +20,215	+3%	+$59.7K	﹤0.01%	2351
2019 Q1	$2.29M	Buy	775,024 +37,171	+5%	+$91.3K	﹤0.01%	2320
2018 Q4	$1.17M	Sell	737,853 -18,778	-2%	-$53.1K	﹤0.01%	2496
2018 Q3	$2.79M	Buy	756,631 +98,287	+15%	+$293K	﹤0.01%	2320
2018 Q2	$1.86M	Sell	658,344 -42,504	-6%	-$145K	﹤0.01%	2404
2018 Q1	$2.6M	Buy	700,848 +151,659	+28%	+$496K	﹤0.01%	2228
2017 Q4	$1.58M	Buy	549,189 +23,577	+4%	+$85.7K	﹤0.01%	2383
2017 Q3	$2.36M	Buy	525,612 +68,271	+15%	+$303K	﹤0.01%	2230
2017 Q2	$2.1M	Buy	457,341 +2,850	+0.6%	+$11.5K	﹤0.01%	2205
2017 Q1	$1.91M	Buy	454,491 +25,650	+6%	+$107K	﹤0.01%	2216
2016 Q4	$1.77M	Sell	428,841 -12,019	-3%	-$63.9K	﹤0.01%	2227
2016 Q3	$3.57M	Buy	440,860 +21,490	+5%	+$183K	﹤0.01%	1850
2016 Q2	$3.27M	Buy	419,370 +28,264	+7%	+$242K	﹤0.01%	1824
2016 Q1	$3.02M	Buy	391,106 +8,011	+2%	+$58.7K	﹤0.01%	1827
2015 Q4	$4.13M	Buy	383,095 +25,002	+7%	+$227K	0.01%	1650
2015 Q3	$2.48M	Buy	358,093 +22,162	+7%	+$181K	﹤0.01%	1946
2015 Q2	$2.98M	Buy	335,931 +10,011	+3%	+$94.7K	﹤0.01%	1874
2015 Q1	$3.21M	Buy	325,920 +59,817	+22%	+$747K	﹤0.01%	1787
2014 Q4	$3.26M	Buy	266,103 +4,142	+2%	+$50.6K	﹤0.01%	1725
2014 Q3	$2.62M	Buy	261,961 +28,075	+12%	+$261K	﹤0.01%	1809
2014 Q2	$1.77M	Buy	233,886 +18,200	+8%	+$72.6K	﹤0.01%	2040
2014 Q1	$710K	Buy	215,686 +6,000	+3%	+$21K	﹤0.01%	2447
2013 Q4	$697K	Sell	209,686 -1,059	-0.5%	-$3.07K	﹤0.01%	2445
2013 Q3	$559K	Buy	210,745 +21,649	+11%	+$148K	﹤0.01%	2506
2013 Q2	$1.58M	Buy	+189,096	New	+$1.44M	﹤0.01%	1904